<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001946'>Ketosis</z:hpo>-prone <z:mp ids='MP_0002055'>diabetes</z:mp> (KPD) is a phenotypically defined form of <z:mp ids='MP_0002055'>diabetes</z:mp> characterized by male predominance and severe insulin deficiency </plain></SENT>
<SENT sid="1" pm="."><plain>Neurogenin3 (NGN3) is a proendocrine gene, which is essential for the fate of pancreatic beta cells </plain></SENT>
<SENT sid="2" pm="."><plain>Mice lacking ngn3 develop early insulin-deficient <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, we hypothesized that gender and variants in NGN3 could predispose to KPD </plain></SENT>
<SENT sid="4" pm="."><plain>We have studied clinical and metabolic parameters according to gender in patients with KPD (n = 152) and common type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (T2DM) (n = 167) </plain></SENT>
<SENT sid="5" pm="."><plain>We have sequenced NGN3 in KPD patients and screened gene variants in T2DM and controls (n = 232) </plain></SENT>
<SENT sid="6" pm="."><plain>In KPD, male gender was associated with a more pronounced decrease in beta-cell insulin secretory reserve, assessed by fasting C-<z:chebi fb="7" ids="16670">peptide</z:chebi> [mean (ng/ml) +/- s.d., M: 1.1 +/- 0.6, F: 1.5 +/- 0.9; p = 0.02] and glucagon-stimulated C-<z:chebi fb="7" ids="16670">peptide</z:chebi> [mean (ng/ml) +/- s.d., M: 2.2 +/- 1.1, F: 3.1 +/- 1.7; p = 0.03] </plain></SENT>
<SENT sid="7" pm="."><plain>The rare affected females were in an <z:e sem="disease" ids="C0429468" disease_type="Disease or Syndrome" abbrv="">anovulatory</z:e> state </plain></SENT>
<SENT sid="8" pm="."><plain>We found two new variants in the promoter [-3812T/C (af: 2%) and -3642T/C (af: 1%)], two new coding variants [S171T (af: 1%) and A185S (af: 1%)] and the variant already described [S199F (af: 69%)] </plain></SENT>
<SENT sid="9" pm="."><plain>These variants were not associated with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Clinical investigation revealed an association between <z:chebi fb="0" ids="36940">199F</z:chebi> and <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> assessed by glycated <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> [HbA1c (%, +/-s.d.) S199: 12.6 +/- 1.6, S199F: 12.4 +/- 1.4 and <z:chebi fb="0" ids="36940">199F</z:chebi>: 14.1 +/- 2.2; p = 0.01] </plain></SENT>
<SENT sid="11" pm="."><plain>In vitro, the P171T, A185S and S199F variants did not reveal major functional alteration in the activation of NGN3 target genes </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, male gender, <z:e sem="disease" ids="C0429468" disease_type="Disease or Syndrome" abbrv="">anovulatory</z:e> state in females and NGN3 variations may influence the pathogenesis of KPD in West Africans </plain></SENT>
<SENT sid="13" pm="."><plain>This has therapeutic implications for potential tailored pharmacological intervention in this population </plain></SENT>
</text></document>